| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 167.44B | 167.09B | 162.93B | 158.25B | 140.94B | 116.31B |
| Gross Profit | 17.05B | 16.52B | 14.97B | 13.48B | 10.07B | 7.21B |
| EBITDA | 16.54B | 15.40B | 15.10B | 15.09B | 12.93B | 9.50B |
| Net Income | -2.40B | 3.58B | -2.89B | -7.70B | -84.00M | -5.19B |
Balance Sheet | ||||||
| Total Assets | 130.46B | 136.26B | 134.09B | 131.76B | 137.07B | 131.30B |
| Cash, Cash Equivalents and Short-Term Investments | 12.76B | 12.87B | 13.55B | 12.32B | 12.99B | 9.36B |
| Total Debt | 36.84B | 39.43B | 41.01B | 40.94B | 44.37B | 43.62B |
| Total Liabilities | 80.11B | 80.31B | 82.10B | 80.15B | 80.29B | 77.73B |
| Stockholders Equity | 50.34B | 55.94B | 51.99B | 51.62B | 56.65B | 53.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.31B | 432.00M | 5.20B | 839.00M | -989.00M |
| Operating Cash Flow | 0.00 | 12.90B | 15.31B | 18.32B | 10.73B | 8.26B |
| Investing Cash Flow | 0.00 | -12.18B | -12.89B | -13.94B | -6.33B | -6.08B |
| Financing Cash Flow | 0.00 | -2.52B | -1.04B | -5.95B | -1.53B | -5.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.01B | 8.10 | ― | 2.87% | 3.04% | 38.35% | |
74 Outperform | ¥12.86B | 10.82 | ― | 4.93% | 1.21% | 13.56% | |
65 Neutral | ¥17.56B | 4.82 | ― | 4.33% | 2.56% | ― | |
65 Neutral | ¥10.67B | 38.46 | ― | 3.48% | 3.10% | -60.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥15.34B | -6.73 | ― | ― | -3.09% | -68.39% | |
46 Neutral | ¥4.25B | -1.71 | ― | 1.06% | 8.16% | -1033.93% |